Exelixis reported $1.84B in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Akebia Therapeutics AKBA:US $ 302.69M 30.68M
Amgen AMGN:US $ 18520M 865M
AstraZeneca AZN:LN 22.65B 3.6B
Bayer BAYN:GR 38.25B 5.67B
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Cytokinetics CYTK:US $ 623.53M 87.85M
Eisai 4523:JP Y 640606M 53549M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
Exelixis EXEL:US $ 1842.74M 8M
Genmab GEN:DC 23.18B 439M
Glaxosmithkline GSK:US $ 28988M 10314M
Immunogen IMGN:US $ 456.72M 43.28M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Macrogenics MGNX:US $ 218.2M 61.36M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Moderna Inc MRNA:US 16.35B 279M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Puma Biotechnology PBYI:US $ 117.57M 22.45M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Takeda 4502:JP Y 2593642M 115749M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Xencor XNCR:US $ 505.97M 81.6M
YTE INCY:US $ 3288.09M 169.42M